Walmsley R. World prison population list (12th edition). London: Institute for Criminal Policy Research; 2018.
Google Scholar
World prison brief data: Belgium [https://www.prisonstudies.org/country/belgium].
Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H, et al. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology. 2013;58(4):1215–24. https://doi.org/10.1002/hep.26387.
Article
PubMed
Google Scholar
Rich JD, Beckwith CG, Macmadu A, Marshall BDL, Brinkley-Rubinstein L, Amon JJ, et al. Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis. Lancet. 2016;388(10049):1103–14. https://doi.org/10.1016/S0140-6736(16)30379-8.
Article
PubMed
PubMed Central
Google Scholar
Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388(10049):1089–102.
Article
PubMed
Google Scholar
Busschots D, Toghanian S, Bielen R, Salomonsson S, Koc OM, Hendrickx G, et al. Eliminating viral hepatitis C in Belgium: the micro-elimination approach. BMC Infect Dis. 2020;20(1):181. https://doi.org/10.1186/s12879-020-4898-y.
Article
PubMed
PubMed Central
Google Scholar
Muyldermans G, Bielen R, Botterman R, Bourgeois S, Colle I, Deressa B, et al. Hepatitis C virus (HCV) prevalence estimation in the adult general population in Belgium : a meta-analysis. Acta Gastroenterol Belg. 2019;82(4):479–85.
CAS
PubMed
Google Scholar
ECDC. Systematic review on hepatitis B and C prevalence in the EU/EEA. In: Edited by control ECfDPa. Stockholm: European Centre for Disease Prevention and Control; 2016.
Google Scholar
Arain A, Robaeys G, Stover H. Hepatitis C in European prisons: a call for an evidence-informed response. BMC Infect Dis. 2014;14(Suppl 6):S17.
Article
PubMed
PubMed Central
Google Scholar
WHO. Prisons and health. Copenhagen: WHO; 2014.
ECDC. Surveillance and prevention of hepatitis B and C in Europe. Stockholm: European Centre for Disease Prevention and Control; 2010.
Google Scholar
Stone K. The global state of harm reduction 2016. London: Harm Reduction International; 2016.
Google Scholar
Walker M, Kautz A, Chavdarova L. Hepatitis B and C - an action plan for saving lives in europe; 2015. p. 44.
Google Scholar
Costella A, Craine N, Goldberg D, Harris H, Hutchinson S, Jessop L, et al. Hepatitis C in the UK; 2017 report; 2017. p. 34.
Google Scholar
Rumble C, Pevalin DJ, O'Moore E. Routine testing for blood-borne viruses in prisons: a systematic review. Eur J Pub Health. 2015;25(6):1078–88. https://doi.org/10.1093/eurpub/ckv133.
Article
Google Scholar
de la Flor C, Porsa E, Nijhawan AE. Opt-out HIV and hepatitis C testing at the Dallas County jail: uptake, prevalence, and demographic characteristics of testers. Public Health Rep. 2017;132(6):617–21. https://doi.org/10.1177/0033354917732755.
Article
PubMed
PubMed Central
Google Scholar
Morris MD, Brown B, Allen SA. Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health. Int J Prison Health. 2017;13(3–4):192–9. https://doi.org/10.1108/IJPH-07-2016-0028.
Article
PubMed
PubMed Central
Google Scholar
Martin NK, Vickerman P, Brew IF, Williamson J, Miners A, Irving WL, et al. Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis. Hepatology. 2016;63(6):1796–808.
Article
PubMed
Google Scholar
He T, Li K, Roberts MS, Spaulding AC, Ayer T, Grefenstette JJ, et al. Prevention of hepatitis C by screening and treatment in U.S. prisons. Ann Intern Med. 2016;164(2):84–92. https://doi.org/10.7326/M15-0617.
Article
PubMed
Google Scholar
Rich JD, Allen SA, Williams BA. Responding to hepatitis C through the criminal justice system. N Engl J Med. 2014;370(20):1871–4. https://doi.org/10.1056/NEJMp1311941.
Article
CAS
PubMed
Google Scholar
Larney S, Beckwith CG, Zaller ND, Montague BT, Rich J. “Seek, test, treat and retain” for hepatitis C in the United States criminal justice system. Int J Prison Health. 2014;10(3):164–71. https://doi.org/10.1108/IJPH-11-2013-0051.
Article
PubMed
PubMed Central
Google Scholar
Lazarus JV, Wiktor S, Colombo M, Thursz M, Foundation EIL. Micro-elimination - a path to global elimination of hepatitis C. J Hepatol. 2017;67(4):665–6. https://doi.org/10.1016/j.jhep.2017.06.033.
Article
PubMed
Google Scholar
WHO. Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. Geneva: World Health Organization; 2016. p. 138.
Google Scholar
Smith JM, Uvin AZ, Macmadu A, Rich JD. Epidemiology and treatment of hepatitis B in prisoners. Curr Hepatol Rep. 2017;16(3):178–83. https://doi.org/10.1007/s11901-017-0364-8.
Article
PubMed
PubMed Central
Google Scholar
Koc OM, Kremer C, Bielen R, Buscchots D, Hens N, Nevens F, et al. Prevalence and risk factors of hepatitis B virus infection in middle-Limburg Belgium, year 2017: importance of migration. J Med Virol. 2019;91(8):1479–88. https://doi.org/10.1002/jmv.25457.
Article
CAS
PubMed
Google Scholar
Sasse A, Deblonde J, De Rouck M, Montourcy M, Van Beckhoven D. Epidemiologie van AIDS en HIV-infectie in België. Brussels: Wetenschappelijk Instituut Volksgezondheid; 2018.
Google Scholar
Sayyah M, Rahim F, Kayedani GA, Shirbandi K, Saki-Malehi A. Global view of HIV prevalence in prisons: a systematic review and meta-analysis. Iran J Public Health. 2019;48(2):217–26.
PubMed
PubMed Central
Google Scholar
Meyer JP, Cepeda J, Wu J, Trestman RL, Altice FL, Springer SA. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate. JAMA Intern Med. 2014;174(5):721–9. https://doi.org/10.1001/jamainternmed.2014.601.
Article
PubMed
PubMed Central
Google Scholar
Small W, Wood E, Betteridge G, Montaner J, Kerr T. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care. 2009;21(6):708–14. https://doi.org/10.1080/09540120802511869.
Article
PubMed
Google Scholar
Belenko S, Dembo R, Copenhaver M, Hiller M, Swan H, Albizu Garcia C, et al. HIV stigma in prisons and jails: results from a staff survey. AIDS Behav. 2016;20(1):71–84. https://doi.org/10.1007/s10461-015-1098-7.
Article
PubMed
PubMed Central
Google Scholar
Culbert GJ, Bazazi AR, Waluyo A, Murni A, Muchransyah AP, Iriyanti M, et al. The influence of medication attitudes on utilization of antiretroviral therapy (ART) in Indonesian prisons. AIDS Behav. 2016;20(5):1026–38. https://doi.org/10.1007/s10461-015-1198-4.
Article
PubMed
PubMed Central
Google Scholar
UNODC. The United Nations standard minimum rules for the treatment of prisoners (the Nelson Mandela Rules). Vienna: United Nations Office on Drugs and Crime; 2015. p. 38.
Google Scholar
CDC: CDC yellow book 2020; 2019.
Google Scholar
Arya R, Antonisamy B, Kumar S. Sample size estimation in prevalence studies. Indian J Pediatr. 2012;79(11):1482–8. https://doi.org/10.1007/s12098-012-0763-3.
Article
PubMed
Google Scholar
Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench. 2013;6(1):14–7.
PubMed
PubMed Central
Google Scholar
Rutterford C, Copas A, Eldridge S. Methods for sample size determination in cluster randomized trials. Int J Epidemiol. 2015;44(3):1051–67. https://doi.org/10.1093/ije/dyv113.
Article
PubMed
PubMed Central
Google Scholar
Kronfli N, Linthwaite B, Kouyoumdjian F, Klein MB, Lebouché B, Sebastiani G, et al. Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: a systematic review. Int J Drug Policy. 2018;57:95–103. https://doi.org/10.1016/j.drugpo.2018.04.003.
Article
PubMed
Google Scholar
Mason LM, Duffell E, Veldhuijzen IK, Petriti U, Bunge EM, Tavoschi L. Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review. Euro Surveill. 2019;24(30):1800614.
Article
PubMed Central
Google Scholar
Masarone M, Caruso R, Aglitti A, Izzo C, De Matteis G, Attianese MR, et al. Hepatitis C virus infection in jail: difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program. Dig Liver Dis. 2020;52(5):541–6. https://doi.org/10.1016/j.dld.2020.02.012.
Article
CAS
PubMed
Google Scholar
Fiore V, De Matteis G, Ranieri R, Saderi L, Pontali E, Muredda A, et al. HCV testing and treatment initiation in an Italian prison setting: a step-by-step model to micro-eliminate hepatitis C. Int J Drug Policy. 2021;90:103055. https://doi.org/10.1016/j.drugpo.2020.103055.
Article
PubMed
Google Scholar
Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45–57. https://doi.org/10.1016/j.jhep.2014.07.027.
Article
PubMed
Google Scholar
Semaille C, Le Strat Y, Chiron E, Chemlal K, Valantin MA, Serre P, et al. Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy. Euro Surveill. 2013;18(28):20524.
Article
PubMed
Google Scholar
Izquierdo L, Mellon G, Buchaillet C, Fac C, Soutiere MP, Pallier C, et al. Prevalence of hepatitis E virus and reassessment of HIV and other hepatitis virus seroprevalences among French prison inmates. PLoS One. 2019;14(6):e0218482. https://doi.org/10.1371/journal.pone.0218482.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chacowry Pala K, Baggio S, Tran NT, Girardin F, Wolff H, Getaz L. Blood-borne and sexually transmitted infections: a cross-sectional study in a Swiss prison. BMC Infect Dis. 2018;18(1):539. https://doi.org/10.1186/s12879-018-3445-6.
Article
PubMed
PubMed Central
Google Scholar
Morey S, Hamoodi A, Jones D, Young T, Thompson C, Dhuny J, et al. Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine. J Viral Hepat. 2019;26(1):101–8. https://doi.org/10.1111/jvh.13017.
Article
PubMed
Google Scholar
Pontali E, Fiore V, Ialungo AM, Ranieri R, Mollaretti O, Barbarini G, et al. Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy. Int J Drug Policy. 2018;59:50–3. https://doi.org/10.1016/j.drugpo.2018.06.017.
Article
PubMed
Google Scholar
Overton K, Clegg J, Pekin F, Wood J, McGrath C, Lloyd A, et al. Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting. Int J Drug Policy. 2019;72:123–8. https://doi.org/10.1016/j.drugpo.2019.02.013.
Article
PubMed
Google Scholar
Papaluca T, McDonald L, Craigie A, Gibson A, Desmond P, Wong D, et al. Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care. J Hepatol. 2019;70(5):839–46. https://doi.org/10.1016/j.jhep.2019.01.012.
Article
PubMed
Google Scholar
Fiore V, Ranieri R, Dell'Isola S, Pontali E, Barbarini G, Prestileo T, et al. Feasibility and efficacy of 8 week Glecaprevir/Pibrentasvir to treat incarcerated viraemic HCV patients: a case-control study. Liver Int. 2021;41(2):271–5. https://doi.org/10.1111/liv.14745.
Article
CAS
PubMed
Google Scholar